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doi:10.1016/j.jtcvs.2007.04.041bjective: Closure of ostium secundum atrial septal defects is generally performed
y using an interventional approach. We evaluated the outcome of patients requiring
econdary surgical therapy.
ethods: From September 1996 until December, 2005, 418 patients received interven-
ional and 297 patients underwent surgical closure of an ostium secundum atrial septal
efect at our center. Another 15 patients (local, 5; regional, 5; and national, 5 referrals)
ad complications after occluder placement, and they form the study population.
esults: Indications for surgical repair in these 15 patients were dislocation of the
ccluder in 5, neurologic events after occluder placement in 5, residual defects in 4,
nd sepsis with questionable occluder infection in 1 patient. A total of 7 patients had
eurologic events, 5 of embolic origin. The interval between interventional occluder
lacement and definitive surgical repair was 319  416 days (median 123 days;
ange 0–1395 days). Patient age at operation was 34.9  18.6 years. Nine patients
ere operated on via an anterolateral minithoracotomy, and 6 received a conven-
ional sternotomy. One patient with sepsis underwent abdominal surgery on post-
perative day 1 and subsequently died of multiorgan failure; there was no proof of
ccluder endocarditis. At 2.2  1.9 years of follow-up, all other patients had
eturned to full-time work without residual neurologic impairment.
onclusions: Complications may arise after interventional ostium secundum atrial
eptal defect closure. This must be evaluated against the extremely low risk of a standard
urgical closure. The functional outcome after secondary surgical ostium secundum
trial septal defect closure with removal of an occluder system is excellent.
trial septal defect (ASD) closure is indicated according to standard criteria.
This includes patients having dyspnea, recurrent respiratory tract infections,
or atrial arrhythmia, having a significant shunt at the atrial level leading to
pulmonary/systemic flow ratio greater than 1.5:1, or being at risk for paradoxic
mbolization.1
Interventional therapy with ASD occluder systems has gained widespread ac-
eptance during the past few years. It is performed whenever technically feasible,
sually in patients with ostium secundum ASD. By comparison, standard surgical
herapy is performed whenever patients are referred by the cardiologists because of
efects not amenable for interventional closure. Thus, the cardiologist is the “gate-
The Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 3 731
k
M
f
s
a
p
c
s
h
p
r
e
e
s
h
r
P
O
I
f
h
r
e
a
a
b
t
p
t
o
l
t
d
c
t
s
h
s
t
r
a
o
r
p
c
l
t
t
(
c
t
I
I
o
a
w
a
n
d
h
1
S
A
A
s in
p
c
p
F
l
m
i
t
Surgery for Congenital Heart Disease Walther et al
7
CH
Deeper,” deciding on which therapeutic option to choose.
ost patients, without knowing too many details, are in
avor of avoiding an operation. There are no randomized
tudies comparing interventional and surgical therapies, nor
re there any regarding short- or long-term outcomes at the
resent time.
Despite the success of occluder placement in most cir-
umstances, some patients need to be referred for standard
urgical therapy after failure of the procedure. These patients
ave different diagnoses, comprising a rather heterogeneous
opulation. Indications for definitive surgical therapy may be
esidual defects, occluder dislocations, thrombus formation,
mbolization, and infection. The aim of this study was to
valuate the results after secondary surgical closure of ostium
ecundum ASD after occluder placement, gathered from a
eterogenous population of local, regional, and distant
eferrals.
atients and Methods
verall Patient Population
nterventional ASD closure has become a routine procedure, per-
ormed successfully in many patients. However, occasionally patients
ave complications that require secondary surgical correction. In this
eport, we present data from a regional center summarizing our
xperience with an equal number of local (n  5), regional (n  5),
nd national (n 5) referrals receiving secondary surgical correction
fter having complications after occluder placement.
All patients admitted for ASD closure are routinely evaluated
y transthoracic and transesophageal echocardiography preopera-
ively. Specific criteria for optional occluder placement include the
resence of at least a 3-mm wide rim at all margins of the defect
o allow for safe anchoring of the device. During the early years of
ccluder placement, from 1995 until 1999, patients having defects
arger than 30 mm were directly referred for surgical therapy. Since
hen, in parallel with the development of larger devices, patients with
efects up to 40 mm have been accepted for occluder placement.
The following numbers should give an idea of the regular
aseload of patients treated with ASD at our center: From Sep-
ember 1996 until December 2005, a total of 418 patients were
cheduled for interventional ASD closure. Of these patients, 38
ad ASDs that were more complex, that is, larger or consisting of
everal defects. The Amplatzer system was used to treat 96.7% of
hese patients. A total of 36 patients (9.4% of the total) were
eferred for surgical treatment, mostly on an elective basis without
ny complications. Reasons for elective referral were no attempt at
ccluder placement owing to larger defect size or missing tissue
im to anchor the device in 12 patients, interrupted placement
rocedure owing to technical reasons, mostly during the learning
urve in 18 patients, residual defects in 3 patients, and late embo-
Abbreviations and Acronyms
ASD atrial septal defect
ECC  extracorporeal circulationization in 1 patient. Early embolization requiring urgent surgical p
32 The Journal of Thoracic and Cardiovascular Surgery ● Septeherapy occurred in 2 patients in this series. Mostly independent of
his series during the same time interval, a total of 15 patients
equal numbers of local, regional, and national referrals) had
omplications after unsuccessful occluder placement. These pa-
ients formed the study population.
ndications for Surgical Repair
ndications for surgical repair in these 15 patients were dislocation
f the device in 5 patients, a neurologic event (transient ischemic
ttack) with or without embolism in 5 patients, residual defects
ith significant shunting causing clinical symptoms in 4 patients,
nd sepsis with the suspicion of an infected device in 1 patient.
From the study population of 15 patients, a total of 7 had had
eurologic incidents at any time, 5 resulting from residual
efects, 1 resulting from endocarditis, and 1 resulting from
eparin-induced thrombocytopenia. Patient age was 34.9 
8.6 years and 11 were female.
urgical Technique
standard surgical technique using a lateral minithoracotomy for
SD closure is routinely applied at out institution whenever fea-
ible, as described previously.2 This approach is being used 
atients with sufficiently large femoral vessels for extracorporeal
irculation (ECC) and a body weight of more than 30 kg. In the
resence of additional diagnoses, a conventional sternotomy ap-
igure 1. Minimally invasive ASD closure using a right antero-
ateral minithoracotomy. The incision is placed in the submam-
ary fold (line) and the thorax is entered through the fourth
ntercostal space. The pericardium is being opened 2 cm anterior
o the phrenic nerve.roach was chosen. All operations were performed with trans-
mber 2007
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Dsophageal echocardiographic monitoring. One venous return can-
ula was introduced percutaneously in the right or left internal
ugular vein by the anesthetists. The anterior aspect of the right or
eft femoral artery and vein was dissected through a 3-cm incision
n the inguinal fold for ECC access. Secured by purse-string
utures (Prolene 5–0; Ethicon, Inc, Somerville, NJ), a 16F to 20F
rterial and a 30F venous return cannula were positioned by the
eldinger technique. The heart was accessed via a right anterolat-
ral minithoracotomy in the submammary fold through the fourth
ntercostal space. The lung (single-lumen intubation) was discon-
ected under ECC support. The pericardium was entered with a
orizontal incision at least 2 cm anterior to the phrenic nerve
Figure 1). The superior and inferior venae cavae were diss
nd snared or a large bulldog clamping device was applied. A
urse-string suture was made on the right lateral aspect of the
scending aorta to apply cardioplegic solution. The aorta was
artially dissected from the pulmonary artery at the anterior and
osterior aspects. A special endoscopic aortic clamp was then
ntroduced through the second intercostal space in the right ante-
ior axillary line. The heart was fibrillated, the aorta clamped, a
ong needle inserted in the ascending aorta, and cardioplegic
olution administered. In parallel, the right atrium was opened.
fter cardioplegia was finished, the ASD occluder was inspected,
nd the correction performed. The aortic clamp was released after
efinitive ASD closure, usually with an autologous pericardial
atch. The right atrium was then closed on the beating and reper-
ABLE 1. Detailed patient information
t.
o
Age
(y) Sex
Weight
(kg)
Initial
diagnosis
Diagnosis before
surgical therapy
1 49 F 62 ASD II Sepsis
2 28 F 53 ASD II Dislocation
3 34 F 60 ASD II Partial embolization
4 75 F 85 ASD II Residual defect
5 39 M 70 PFO Embolization, HIT, NE
6 9 M 25 ASD II Residual defect
7 64 F 65 ASD II Dislocation
8 16 F 49 ASD II Dislocation
9 25 F 49 ASD II Residual defect,
embolization, NE
0 46 F 61 ASD II Residual defect
1 44 F 63 PFO Residual defect,
embolization, NE
2 4 F 19 ASD II Dislocation
3 39 M 78 PFO Residual defect, NE
4 23 M 71 ASD II Embolization, NE
5 29 F 47 ASD II Residual defect
R, Operation; ASD II, secundum atrial septal defect; POD, postoperati
E, neurologic event during the interval between occluder placement and
he authors’ own institution.used heart. a
The Journal of Thoracicetails of the Patient Population
he interval between occluder placement and definitive surgical
orrection was 319  416 days at a median of 123 days (range
-1395 days). Specific details on each patient are given in
able 1.
tatistics
esults are given as mean  standard deviation. Absolute and
elative frequencies were calculated. The Kolmogrov–Smirnov test
as used to assess normal distribution and the Student t test or
ann–Whitney U test was applied as appropriate.
esults
erioperative Results
here were no surgical complications in all patients. A
inimally invasive approach was chosen in 9 patients. In
hese patients no conversions to median sternotomy were
equired. In 5 patients additional procedures were per-
ormed: pulmonary embolectomy in 1, mitral valve repair
n 1, left atrial cryoablation to treat atrial fibrillation in 1,
econstruction of the noncoronary aortic sinus with a
ericardial patch after resection of an occluder that had
roded into the aortic wall in 1, and redirection of the
ight inferior pulmonary veins in the presence of partially
R date
(mo/y)
Interval occluder–
operation (d) Additional therapy Institution
ne ‘98 180 Abdominal surgery
POD 1
ov ‘98 34
ept ‘99 115
ov 00 1395
n ‘01 10 Pulmonary
embolectomy
n ‘01 1 Redirection of
pulmonary veins
HZL
ug ‘02 184 Cryoablation of left
atrium
ct ‘02 0 HZL
ay ‘03 591
ay ‘03 123 HZL
n ‘03 122 HZL
ct ‘04 0 HZL
ct ‘04 742
b ‘05 940 Mitral valve repair
ec ‘05 210 Repair aortic root,
noncoronary sinus
y; PFO, patent foramen ovale; HIT, heparin-induced thrombocytopenia;
tive surgical therapy. HZL in the last column indicates Heartcenter Leipzig,O
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defininomalous pulmonary venous drainage in 1 patient. An
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Dverview on the individual patient profiles is given in
able 1.
ECC duration was 65  12 minutes and aortic cross-
lamp time was 30 11 minutes. Duration of postoperative
ntubation was 7.4  6 hours and mean left ventricular
jection fraction was 66%  7%. An example of a residual
efect at the superior rim of the occluder is shown in
igure 2.
One patient died on postoperative day 1. She was in
table cardiac condition. However, she was in profound
epsis preoperatively and underwent emergency explanta-
ion of the occluder owing to suspected infection of the
evice. There was no microbiologic proof of endocarditis
rom intraoperatively taken cultures. The next day the pa-
ient died of progressive septic multiorgan failure with
ubsequent bowel ischemia despite emergency abdominal
urgery. In another patient, rethoracotomy had to be per-
ormed owing to bleeding from an intercostal artery after
ateral minithoracotomy. No other patients (n  13) re-
uired any repeat surgical intervention. At the end of sur-
ical correction, a follow-up transesophageal echocardio-
ram showed a securely closed atrial septum in all 15
atients without any residual defect. Of these patients, 14
ere in sinus rhythm.
ischarge and Follow-up
he 14 survivors were discharged from the hospital without
urther complications. Transthoracic echocardiography re-
ealed good functional results in all of them. There were no
elevant further lesions, especially no relevant tricuspid
alve incompetence in any of the patients and good aortic
alve function in the 1 patient undergoing reconstruction of
he noncoronary aortic sinus.
All patients were contacted by telephone interview for
urther follow-up. All were alive. The interval between
igure 2. Example of a residual defect after occluder placement
ith the tip of the suction passing into the left atrium. The defect
as at the superior rim close to the insertion of the superior vena
ava. Direct view through the right atrial incision.urgical correction and the follow-up interview was 2  1.9 o
34 The Journal of Thoracic and Cardiovascular Surgery ● Septeears. All patients had returned to full-time work. Most
mportant, there was no relevant residual neurologic impair-
ent in any of the patients. None of the patients had had any
epeat symptoms. All patients were in New York Heart
ssociation class I. Regarding quality of life, 12 patients
entioned that it had improved and 2 that it was unchanged
ompared with the preoperative status.
iscussion
he definitive therapy for ASDs has been surgical closure
or more than 5 decades with excellent long-term resul2-9
nterventional approaches involving approved and commer-
ially available occluder systems have been performed in
atients who have ostium secundum ASDs since the
990s.10-12 Recently, more complex and larger defects 
eing treated interventionally, and overall numbers are in-
reasing. Future directions may aim at avoiding the implan-
ation of relatively large discs of foreign material by using
direct suturing technique.
At present, only patients with complex defects are being
eferred for definitive surgical therapy. Another group of
eferrals includes those who have had unsuccessful attempts
o place an occluder or who have experienced complications
fter undergoing interventional procedures for ASD closure.
ommunication with several cardiac surgeons from differ-
nt centers reveals that most have experience with explant-
ng a smaller number of devices for different reasons. How-
ver, the overall number of patients requiring explantation
f occluder devices may be low in relation to the total
mplantation rate.
One important and interesting article has been recently
ublished by Divekar and colleagues.13 They focused on
evice-related cardiac events and especially on the inci-
ence of cardiac perforations. From among more than
4,000 implanted occluder devices, a total of 29 cardiac
vents were reported, including 5 deaths and 3 neurologic
vents. This underlines the fact that there is a low but
nherent risk. Another overview on potential erosion of the
mplatzer septal occluder device identified 28 patients, at
n overall incidence of 0.1%, in the United States.14 Patients
ith deficient aortic and/or superior rim were judged as
eing at higher risk to have such a complication.14 Unfor-
unately, it seems that few patients know much about these
otential risks. For planned occluder placement, informed
onsent will most certainly be obtained by the cardiologists
nly before starting the procedure. Patient knowledge about
otential complications, however, might lead to a change in
he preferred treatment approach of some. Nevertheless,
ost patients will not choose surgery as an option because
hey believe that interventional therapy is safe. Furthermore,
ardiologists see the patients first, underlining their specific
ole as “gatekeepers” for further referral while keeping their
wn interests of interventional closure in mind. Obviously,
mber 2007
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Droblems with occluder devices are rare. However, patients
hould be informed objectively about all potential risks.
efinitive surgical therapy has some perioperative impact
ut hardly any risk and, most important, excellent long-term
unctional outcome. Use of a flexible autologous pericardial
atch for defect closure guarantees an almost perfect phys-
ologic outcome without any reported risk of endocarditis.
here is essentially no mortality in the current era. Mini-
ally invasive techniques have evolved as very reliable and
ave become the clinical standard in experienced hands.
The most important result from this study is that defin-
tive surgical therapy can be performed safely with good
unctional outcome after complications of occluder place-
ent. This is even true in the presence of severe complica-
ions: for example, impairment of tricuspid valve function
r penetration of the device into the aortic root. Another
mportant finding is that a significant number of these
atients—one third after occluder placement and almost
alf of the patients in total—had some form of neurologic
nsult before definitive surgical closure of the defect. De-
pite this, the postoperative functional outcome was good.
his is clearly underlined by the fact that all patients fully
eturned to their preoperative routine work.
When evaluating the overall data, cardiologists and sur-
eons should agree on what has to be considered a compli-
ation and what complication rate with interventional ASD
losure should be considered as being acceptable. From the
atient’s perspective, any nonoptimal outcome, a residual
efect or additional complication, is unfavorable. Therefore,
he cardiologist and surgeon must strive for an optimal
esult regardless of the technique that is chosen. The attempt
t interventional ASD closure during routine cardiac cath-
terization with subsequent elective referral to surgical ther-
py was occurring in close to 10% of patients from our local
eries, but this should not be considered a complication.
his rate reflects the current practice of attempted interven-
ional closure, triggered by the patient=s interest, whenever
minimal chance of successful percutaneous treatment is
resent. In contradiction, any residual defect with imperfect
utcome or a severe complication, such as a neurologic
vent, should lead to surgical therapy. The incidence of
evere complications should be well below 1% in experi-
nced centers.
Interventional cardiologists are gaining experience with
ccluder placement. With the exception of the rare event of
artial embolizations, no real life-threatening complication
ill arise from failed attempts. Therefore, no surgical
tandby will be required. However, the conduct of interven-
ional approaches in close proximity to a surgical center
ith some cardiac surgical backup will always be preferable
n our opinion.
Are there any factors that will enable cardiologists andurgeons to foresee potential complications? There may be i
The Journal of Thoracicrelation between occluder size and the risk of complica-
ions.14 The size of the relatively stiff discs being impla
ay be one factor, and the direct distance to the aortic root
nd especially the presence of a sufficient rim at the superior
spect may be important when judging the risks of cardiac
erforation. However, as we evaluate our own data, the
atients requiring surgical therapy after occluder device
lacement are a rather heterogenic population. Equal num-
ers of patients having complications after device place-
ent have been referred over the years. Therefore, at
resent, no clear risk factors can be identified.
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iscussion
r Carl L. Backer (Chicago, Ill). My only conflict of interest is
hat I am a surgeon. The first question is, are there any cardiolo-
ists in the audience?
I want to congratulate Dr Walther and colleagues for focusing
ur attention, and ideally that of the interventional cardiologists,
n this relatively new indication for surgery in patients with
ongenital heart disease. That new indication is surgical ASD
losure after attempted device placement in the cardiac catheter-
zation laboratory.
and Cardiovascular Surgery ● Volume 134, Number 3 735
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DOf concern, Dr Walther has reported a nearly 10% incidence
f surgical intervention for patients having complications of
evice placement. Within that group of patients, the most
oncerning are those requiring emergency surgery or those who
ad neurologic events. Two patients required an emergency
peration and 7 patients had serious neurologic issues. One of
hose patients, in fact, died of sepsis after surgical device
emoval and ASD closure. Dr Walther appropriately compares
hese results with a 0% mortality with negligible morbidity in a
eries of surgical ASD closures totaling nearly 1000 patients.
At Children’s Memorial Hospital in Chicago, our series of
urgical ASD closures is now 237 patients since 1990 with no
ortality. Since 1997, of 143 patients undergoing attempted de-
ice closure, there were a total of 11 patients who underwent an
nterventional catheterization procedure and then were referred for
urgery. Two patients were referred because the defect was too
arge and there was no room for device placement. Seven patients
ad attempted closure in the catheterization laboratory with the
evice, but were referred for elective surgery because the device
losure was not successful. Two patients had attempted device
losure and required emergency operation when the device embo-
ized to the mitral valve and to the left atrium. Our incidence of
equirement for surgical intervention of 7.7% is very similar to
ours.
I have 3 questions and a comment. First, should surgical
ackup always be available on site when these interventional cases
re done?
Dr Walther. Thank you very much for that question. I person-
lly think that interventional procedures should only be done in a
enter where there is a cardiac surgeon in-house. However, the
ardiologists will probably go on and implant the devices in
atients as much as they want because no one can stop them. They
robably will not accept it if they are told they can only do that if
backup is available.
Dr Backer. My second question relates to the patients who
ave an attempted but unsuccessful transcatheter closure with the
evice and are hence exposed to general anesthesia, potential
roblems of femoral vessel cannulation, possible device emobo-
ization, et cetera. What do you think is an appropriate incidence of
nsuccessful device placement during this procedure? To me, 7%
o 10% seems to be rather high.
Dr Walther. You are right. The procedure is getting clinically
outine now. I think it should have a failure rate of less than 1%.
do not consider it a device failure when the patient is taken to the
atheterization laboratory, the defect is found to be too large, and
he cardiologists choose to send the patient to us for elective
urgical repair. Failures are cases in which there is an embolization
f the device or there is a marked position of the device wherein
he tricuspid valve is impaired, for example. I think such compli-
ations should be below 1%.
Dr Backer. Finally, can we somehow decrease the number of
atients subjected to the expense and risk of device closure without
successful result by establishing better patient selection criteria?
Dr Walther. That is a very important question, but a very
ifficult one. The cardiologist is the gatekeeper, and he or she will
nly send us those patients whose ASDs cannot be closed inter-
entionally. s
36 The Journal of Thoracic and Cardiovascular Surgery ● SepteOne of the goals in our group is to bring this issue to the
ttention of more patients. It would be very good to have a joint
iscussion to set up syndication between cardiologists and sur-
eons after the diagnosis is made. However, we are not able to get
he patients unless the cardiologist sends them.
Dr Backer. I had a comment to make, but I will save that
ecause of the number of discussers yet to come.
I will say, though, that surgical ASD closure is an extraordi-
arily safe and efficacious operation with minimal morbidity that
hould not be forgotten but actually considered the benchmark
hen considering alternative methods for ASD closure.
Dr Christopher Knott-Craig (Oklahoma City, Okla). Was
here a common denominator in the patients who required surgery
fter ASD device closure? For example, were the sizes of the
evices that were placed unusually large?
Dr Walther. It is difficult to say because we have different
eferrals from different areas. It is not an all-comers series. But
asically, so far as I understand, cardiologists are going up with the
izes. Five to 8 years ago they did not use a 38-mm Amplatzer
evice; the upper limit was 30 mm in the late 1990s. Now they use
lmost 40-mm devices. Therefore, I think it is a change in indica-
ion for them.
Dr Giovanni Stellin (Padova, Italy). I have just reviewed a
anuscript that will be published in the Italian journal, reporting
n a case of late embolization after device ASD closure. The
evice embolized in the pulmonary artery and that was discovered
months after the implantation. I was wondering whether, in your
xperience, you have found any late embolizations? This has
lready been reported as a possibility.
Dr Walther. There was one such case, but it was after a few
eeks; it was not that late.
Dr Stellin. That was 6 months later.
Dr Walther. They are basically talking about these patients to
ther surgeons. We have discussed this situation in the German
ongenital surgical group. Everyone has seen a few such cases, I
hink. We need to set up a multicenter evaluation to really bring
ogether all data from different centers.
Dr Backer. I just want to ask, with a raise of hands, how many
eople have taken Amplatzer devices out of the atrium or femoral
essels or elsewhere? [Show of hands.] That is nearly everyone!
et me ask in a different way: Are there any congenital heart
urgeons here who have not removed an Amplatzer device some-
ime in their career? [Show of hands.] Only three hands go up!
Dr Charles D. Fraser, Jr (Houston, Tex). I would like to make
couple of comments.
The first problem, of course, is the issue that Dr Backer ob-
erved in his opening sentence. There are no pediatric cardiologists
ere. To really make an impact on these various issues, which are
ontinuing to evolve, we are going to have to make sure that these
ata are shared in a forum where a truly meaningful discussion can
o on about what is the best therapy for closing holes in hearts.
Might you reconsider what a failure is? Of course, the failure to
patient is when you are told you have an ASD and you come to
he hospital to get it closed and you go home still having an ASD.
In our institution, what happens frequently is that the patient
omes to the hospital, undergoes a general anesthetic, possibly a
ransesophageal echocardiogram, perhaps an intravascular ultra-
ound, and then is told that the defect is too large and is sent home.
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Walther et al Surgery for Congenital Heart Diseasehe patient gets charged, the insurance company gets charged, and
hen the patient comes back for surgical closure. That, to me, is a
ailure. I think that should be considered in the statistics. It is
ertainly a very expensive mode of therapy. Might you look at
our data a little bit differently in that regard?
Dr Walther. Basically, you are right. That if the patient leaves
he hospital with a residual ASD, that is a failure. But we were
ooking at severe complications, for instance, if there are no
ymptoms in such a patient. It is a question of definition.
Dr Pedro del Nido (Boston, Mass). The device industry is
hat I would call disruptive technology. As such, it is always
orse than the standard therapy for a period of time. Eventually,
owever, the technology gets better. All you have to do is look at
omputers to have a good example; a lot of the original equipment
hat we had years ago, now we would not even look at. I do not
now that it is a good idea to just dismiss the problems with
evices as complications of a bad system.
The cardiologists are very much aware of these problems.
ortic erosion has been described, but it has been primarily de-
cribed for the larger devices, and interventionalists are changing
heir practice. Do you have an idea what the size was in the devices
mplanted? Did you actually measure the size of your devices or
et the procedure notes to determine the size of the devices that
ere put in?
Dr Walther. Unfortunately, I do not have all those data be-
ause these were natural referrals and we do not get the procedure
eports from all of those.
Dr del Nido. It is important to try to learn from these cases. In
he interventional world, such cases are coming out now, although k
The Journal of Thoracicome of them have not made it to print yet. The larger devices, and
nything over about 36 mm is considered the larger size, are the
nes that are causing the complications. This problem occurs with
uch less frequency with the smaller devices. The importance of
his is that if you have a large cohort of patients who are out there
ith larger devices in place, then close follow-up is absolutely
mperative. There have been instances of late left atrial erosion,
ortic root erosion, and mitral valve erosion, especially the cases in
hich there was no rim and the device was deliberately oversized
o capture the rim of the aorta.
Dr Backer. Can I just make a quick comment? I was going to
dd this to my discussion.
I agree with you, Dr del Nido, that the cardiologists are aware
f this problem. But I disagree with the way they interpret the data.
his article that I am quoting is from Catheterization and Cardio-
ascular Interventions (2004;63:496-502), and it is the Amplatzer
tudy group. They discuss erosion of Amplatzer septal occluder
evices and their recommendations are as follows: “Patients with
eficient aortic rim and/or superior rim may be at higher risk
or device erosion. Oversized Amplatzer device may increase the
isk of erosion. The defect should not be overstretched during
alloon sizing. Patients with small pericardial effusion at 24 hours
hould have closer follow-up.”
Nowhere in that conclusion does it say that thought should be
iven to sending the patient to surgery if an oversized device is
eeded or if there is lack of a superior rim or of an aortic rim.
The cardiologists are not looking to the surgeons to treat these
atients; they are looking for ways of tweaking their system to
eep the patients within the device closure strategy.
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